Using ultrasound to place IV catheters in cancer emergency patients
Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths
This study is testing whether different lengths of IV catheters can improve the success of placing them in cancer patients who have trouble with their veins during emergencies.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06217783 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the impact of different catheter lengths on the success and failure rates of ultrasound-guided intravenous (IV) catheter placements in patients experiencing oncologic emergencies. The study aims to determine the rate of catheter failure, defined as removal for reasons other than completion of care, within a 10-day period. Secondary objectives include analyzing the time from catheter placement to removal, the rate of repeat catheterizations, and the incidence of complications such as infection and thrombosis. Participants will be adults with difficult IV access who are expected to stay in the hospital for more than 48 hours.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with difficult IV access who are expected to be hospitalized for more than 48 hours.
Not a fit: Patients who are expected to be discharged shortly or those unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the effectiveness and safety of IV catheter placements in patients with cancer-related emergencies.
How similar studies have performed: Other studies have shown varying success with ultrasound-guided IV placements, but this specific focus on catheter length is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age \> 18 years old. 2. Provision of signed and dated informed consent form. 3. Predetermined to have difficult IV access necessitating USIV placement 4. Expected admission to hospital with anticipated stay \> 48 hours (per discussion with treating physician). Exclusion Criteria: 1. Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician). 2. Inability to give informed consent. 3. Pregnant women. 4. Non-English speaking participants.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Jonathan Rowland, MD — M.D. Anderson Cancer Center
- Study coordinator: Jonathan Rowland, MD
- Email: jwrowland@mdanderson.org
- Phone: (832) 450-8954
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.